EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metalloantibiotics Against ESKAPE Pathogens: Bridging Antibacterial Activity and Clinical Translation

Laura Rodríguez-Silva, Cristina Núñez, María Rodríguez-Padrón, Isabel Velo-Heleno, Marcelino Maneiro

Pharmaceuticals · 25.10.2026 · 19 (11) · 1682

DOI: 10.3390/ph19111682 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 25.10.2026. Verfasst von Laura Rodríguez-Silva und 4 weiteren Autor:innen. Die Arbeit nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institute of Health Carlos III, Xunta de Galicia.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antimicrobial resistance (AMR) in ESKAPE pathogens represents a major threat to infectious disease therapy and has stimulated interest in metal-based antibacterial agents as complements or alternatives to conventional organic antibiotics. Their diverse coordination geometries, tunable redox properties, ligand-exchange behaviour, and capacity to interact with multiple biological targets offer distinctive opportunities for antibacterial drug development. However, despite the potent in vitro activity reported for numerous compounds, progression towards clinical application remains limited. This critical narrative review evaluates the evidence on chemical identity and speciation, causal mechanisms, and pharmacological exposure required to advance metal-based antibacterial candidates towards clinical translation, using gold, bismuth, gallium, copper, silver, and ruthenium compounds as comparative case studies. Three recurrent limitations are identified: insufficient characterisation of metal-complex speciation under biologically relevant conditions; reliance on minimum inhibitory concentration (MIC) measurements and indirect assays to infer molecular targets or causal mechanisms without rigorous validation; and the scarcity and poor integration of pharmacokinetic, safety, and in vivo efficacy data. The available evidence reveals compound-specific advances, including the repurposing potential of auranofin, bismuth-mediated inhibition of New Delhi metallo-β-lactamase 1 (NDM-1), and the clinical evaluation of gallium nitrate in chronic Pseudomonas aeruginosa airway infection in people with cystic fibrosis. Nevertheless, these findings cannot be extrapolated to entire metal classes. The review translates these gaps into four research priorities and candidate-progression criteria to guide experimental design and decisions to advance, reformulate, or discontinue candidate development.

Förderung

  • Institute of Health Carlos III
  • Xunta de Galicia

Zitieren

APA

Rodríguez-Silva, L., Núñez, C., Rodríguez-Padrón, M., Velo-Heleno, I., & Maneiro, M. (2026). Metalloantibiotics Against ESKAPE Pathogens: Bridging Antibacterial Activity and Clinical Translation. Pharmaceuticals, 19(11), 1682. https://doi.org/10.3390/ph19111682

Vancouver

Rodríguez-Silva L, Núñez C, Rodríguez-Padrón M, Velo-Heleno I, Maneiro M. Metalloantibiotics Against ESKAPE Pathogens: Bridging Antibacterial Activity and Clinical Translation. Pharmaceuticals. 2026;19(11):1682. doi:10.3390/ph19111682

BibTeX
@article{RodrguezSilva2026,
  author = {Rodríguez-Silva, Laura and Núñez, Cristina and Rodríguez-Padrón, María and Velo-Heleno, Isabel and Maneiro, Marcelino},
  title = {Metalloantibiotics Against ESKAPE Pathogens: Bridging Antibacterial Activity and Clinical Translation},
  journal = {Pharmaceuticals},
  year = {2026},
  volume = {19},
  number = {11},
  pages = {1682},
  doi = {10.3390/ph19111682}
}
Kostenlos starten →